Gerresheimer AG GXI.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Gerresheimer AG statistics & valuation
Market cap€940.2M
P / S0.4×
P / B0.9×
Net margin-13.8%
Return on equity-29.6%
FCF margin-4.3%
Net debt€2.0B
Enterprise value USD$3.4B
Earnings yield EBIT/EV-2.4%
Return on capital-2.3%
Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 18.3% | 28.5% | 30.0% | 30.1% |
| Operating margin | -3.1% | 9.6% | 11.5% | 10.7% |
| Net margin | -13.8% | 4.1% | 5.8% | 5.3% |
| FCF margin | -4.3% | -6.6% | -1.7% | -1.1% |
| Return on assets | -7.1% | 2.2% | 3.4% | 2.9% |
| Return on equity | -29.6% | 5.6% | 8.1% | 7.7% |
| Debt / equity | 1.40× | 0.59× | 0.43× | 0.51× |
| Current ratio | 0.81 | 0.97 | 0.88 | 0.74 |
Computed from company filings · DE · as of 2025-11-30. Figures in EUR. Facts plus Stocktoria's own computed scores — not investment advice.